Needham raised the firm’s price target on Symbotic (SYM) to $75 from $70 and keeps a Buy rating on the shares. The company posted better-than-expected Q1 revenue and adjusted EBITDA, driven by ongoing growth in system deployment, operational systems and higher paid development revenue that resulted in double-digit adjusted EBITDA margins, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYM:
- Symbotic: Strong Execution, Expanding Margins, and Upwardly Revised Outlook Support Buy Rating and Higher Price Target
- Symbotic Delivers Strong Q1 2026 Results and Profitability
- Symbotic reports Q1 EPS 2c, consensus 9c
- Symbotic sees Q2 revenue $650M-$670M, consensus $639.46M
- Symbiotic options imply 15.7% move in share price post-earnings